Project dates: April 2024 - May 2026
Women who use drugs have a high risk of sexually transmitted infections (STIs) and related adverse sexual and reproductive health outcomes, and treating drug use could reduce substance use and sexual risk behavior while also increasing STI/HIV testing uptake, which in turn may ultimately reduce STI risk.
The goal of the study is to measure the associations between drug treatment and STI incidence among women who use drugs, evaluate the potential mediating pathways, and examine whether individual, social, and structural factors may modify these associations. Results will inform targets for actionable interventions to improve women’s health, reduce morbidity and mortality, and address inequities in drug treatment and sexual and reproductive health.
Abstract on NIH RePORTER